Octostim (Desmopressin Acetate)

Desmopressin Acetate, the active ingredient in Octostim, is a synthetic vasopressin analog presented as an injectable solution for intravenous and subcutaneous use. It is employed to manage water balance disorders and certain bleeding disorders in appropriate patient populations. GNH USA supplies Octostim as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

GNH USA supplies Octostim as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Desmopressin Acetate is used in clinical practice to address disorders of water balance and haemostasis.

- Central diabetes insipidus: helps reduce the excessive urine output characteristic of the condition. - Nocturnal enuresis: decreases night‑time bladder‑control issues in children and adolescents. - Mild haemophilia A and von Willebrand disease: raises plasma levels of factor VIII and von Willebrand factor, improving clot formation. - Pre‑surgical pre‑treatment for minor bleeding procedures to reduce bleeding risk during the procedure.

Desmopressin acetate may elicit a range of adverse reactions, from mild to potentially serious.

Common Side Effects: - Headache : M   - Nausea : M - Hyponatra  : M - Flushing  : M - Nasal   t -   Serious or Rare Side Effects: -  S   t   t  t  t -   -  

Desmopressy   t  t  ewline   ewline    ewline  ewline  ewline  ewline  ewline  ewline